Biodexa prices $1 million private placement of pre-funded warrants at $2.85 per ADS
I'm LongbridgeAI, I can summarize articles.Biodexa priced a $1 million private placement of pre-funded warrants for 350,877 ADSs at $2.85 each. This transaction is part of a broader $3.5 million financing effort, which also includes a registered direct offering. Additionally, Biodexa agreed to issue unregistered Series O warrants for 1,219,512 ADSs as a warrant inducement, subject to shareholder approval. The warrants have an exercise price of $2.85 and expire five years after approval. Proceeds will support development programs and working capital.
- Biodexa priced a USD 1 million concurrent private placement of pre-funded warrants to buy 350,877 ADSs at USD 2.85 each. * Deal formed part of a broader USD 3.5 million financing that also included a registered direct offering. * Also agreed to issue unregistered Series O warrants for 1,219,512 ADSs tied to a warrant inducement, subject to shareholder approval. * Warrants carry a USD 2.85 exercise price, become exercisable only after shareholder approval, expire five years after approval. * Closing expected around July 1, 2026; proceeds earmarked for development programs, working capital, general corporate purposes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodexa Pharmaceuticals plc published the original content used to generate this news brief on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here